Drosophila pericardial nephrocytes provide a unique opportunity to assess the effects of APOL1 risk alleles on different endocytic pathways in vivo, and to perform cost effective and large-scale genetic interactive screening to detect interacting molecules that affect endocytic activity and other cell trafficking pathways, and might be therapeutic targets to treat APOL1 kidney diseases. Here, APOL1 is linked to kidney disorder.